Exact Sciences
EXAS
#1544
Rank
A$17.56 B
Marketcap
$94.90
Share price
5.86%
Change (1 day)
-12.20%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$5.65 Billion

According to Exact Sciences's latest financial reports the company's total liabilities are A$5.65 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Exact Sciences - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$4.88 B4.35%
2022-12-31A$4.67 B2.87%
2021-12-31A$4.54 B30.03%
2020-12-31A$3.49 B101.11%
2019-12-31A$1.73 B45.33%
2018-12-31A$1.19 B1095.65%
2017-12-31A$0.10 B72.83%
2016-12-31A$57.91 M13.49%
2015-12-31A$51.02 M75.18%
2014-12-31A$29.13 M129.72%
2013-12-31A$12.68 M-2.56%
2012-12-31A$13.01 M-0.85%
2011-12-31A$13.12 M-20.46%
2010-12-31A$16.5 M-24.67%
2009-12-31A$21.9 M85.49%
2008-12-31A$11.8 M24.28%
2007-12-31A$9.5 M-15.94%
2006-12-31A$11.3 M-37.46%
2005-12-31A$18.07 M-22.85%
2004-12-31A$23.42 M-22.45%
2003-12-31A$30.2 M45%
2002-12-31A$20.83 M157.24%
2001-12-31A$8.09 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$0.55 B-90.12%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.15 B-97.20%๐Ÿ‡บ๐Ÿ‡ธ USA
A$34.84 M-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA
A$97.20 B 1,619.69%๐Ÿ‡ซ๐Ÿ‡ท France